FORT WORTH, Texas, Sept. 29 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today an agreement with Med Pro Associates of Colorado to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company’s line of products within the U.S.
Under the terms of the agreement, Med Pro will market and sell Wound Management Technologies’ CellerateRx and other products on a non-exclusive basis throughout the U.S. The initial focus will be on Wound Management Technologies’ major product, CellerateRx(R), which is used in the management of pressure ulcers, traumatic wounds, diabetic ulcers, first and second degree burns, venous stasis ulcers, ulcers due to arterial insufficiency and superficial wounds. CellerateRx’s patented collagen fragments, which are a fraction of the size of the native collagen molecules and particles found in other products, deliver the benefits of collagen to the body immediately.
Wound Management Technologies CEO Scott Haire said, “This agreement with Med Pro will enable us to offer CellerateRx and other products to hospitals and doctors’ offices in all 50 states. Med Pro has a well established and effective sales and marketing network that we expect will substantially increase our sales.”
Cathy Bradshaw, president of Wound Management’s Wound Care Innovations subsidiary, said, “WCI is excited to have Med Pro representatives marketing CellerateRx extensively throughout the country. We continue to see great results with CellerateRx and have positive feedback from physicians. Our studies continue to support the effectiveness of CellerateRx and having the Med Pro team presenting CellerateRx will increase our exposure and increase sales.”
About Med Pro Associates
Based in Idaho Springs, CO, Med Pro Associates provides national representation to manufacturers selling into the U.S. healthcare markets. The company has 15 regional offices that cover the entire United States.
About Wound Management Technologies, Inc.
Wound Management Technologies, through its subsidiary Wound Care Innovations, markets and distributes wound care products to the healthcare market under patented technology licensed to the company. The company is positioned and seeks to be a leading provider of wound care products. The company’s corporate headquarters are in Fort Worth, Texas. For more information please visit the company’s website at www.celleraterx.com.
An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at www.hawkassociates.com.
A profile for investors can be accessed at http://www.hawkassociates.com/clients/profile/wndm.cfm.
To receive free e-mail notification of future releases for Wound Management Technologies, sign up at www.hawkassociates.com/about/alert/.
Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products in development are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company’s actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company’s operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company’s SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
SOURCE Wound Management Technologies, Inc.
CONTACT: Product information: Cathy Bradshaw, +1-954-315-9242; or
Shareholder relations: Lucy Singleton, +1-817-820-7080; or Investor
relations information: Frank Hawkins or Julie Marshall, Hawk Associates,
+1-305-451-1888, woundmanagement@hawkassociates.com
Web site: http://www.celleraterx.com/
